274
Participants
Start Date
August 11, 2020
Primary Completion Date
March 30, 2022
Study Completion Date
March 31, 2022
Nemolizumab
Participants received either 30 mg or 60 mg dose of nemolizumab as SC injection.
Placebo
Participants received matching placebo as SC injection.
Galderma Investigational Site, Lausanne
Galderma Investigational Site, Jette
Galderma Investigational Site, Brussels
Galderma Investigational Site, Leuven
Galderma Investigational Site, Bern
Galderma Investigational Site, Utrecht
Galderma Investigational Site, Liège
Galderma Investigational Site, Buochs
Galderma Investigational Site, Weinfelden
Galderma Investigational Site, Ghent
Galderma Investigational Site, Sankt Gallen
Galderma Investigational Site, Groningen
Galderma Investigational Site, New York
Galderma Investigational Site, Gyeonggi-do
Galderma Investigational Site, Washington D.C.
Galderma Investigational Site, Morgantown
Galderma Investigational Site, Valence
Galderma Investigational Site, Brest
Galderma Investigational Site, Anderson
Galderma Investigational Site, Toulouse
Galderma Investigational Site, Ormond Beach
Galderma Investigational Site, Bordeaux
Galderma Investigational Site, Miami
Galderma Investigational Site, Aventura
Galderma Investigational Site, Las Palmas de Gran Canaria
Galderma Investigational Site, Murfreesboro
Galderma Investigational Site, Louisville
Galderma Investigational Site, Saint-Etienne
Galderma Investigational Site, Dublin
Galderma Investigational Site, Nantes
Galderma Investigational Site, Cincinnati
Galderma Investigational Site, Indianapolis
Galderma Investigational Site, Saint Joseph
Galderma Investigational Site, Lille
Galderma Investigational Site, Chicago
Galderma Investigational Site, Pierre-Bénite
Galderma Investigational Site, Paris
Galderma Investigational Site, Dallas
Galderma Investigational Site, Paris
Galderma Investigational Site, Rouen
Galderma Investigational Site, Webster
Galderma Investigational Site, Dripping Springs
Galderma Investigational Site, Pflugerville
Galderma Investigational Site, San Diego
Galderma Investigational Site, Fountain Valley
Galderma Investigational Site, North Miami Beach
Galderma Investigational Site, Boston
Galderma Investigational Site, North York
Galderma Investigational Site, Bathurst
Galderma Investigational Site, Calgary
Galderma Investigational Site, London
Galderma Investigational Site, Markham
Galderma Investigational Site, Nice
Galderma Investigational Site, Bydgoszcz
Galderma Investigational Site, Chorzów
Galderma Investigational Site, Krakow
Galderma Investigational Site, Lodz
Galderma Investigational Site, Lodz
Galderma Investigational Site, Lublin
Galderma Investigational Site, Olsztyn
Galderma Investigational Site, Ostrowiec Świętokrzyski
Galderma Investigational Site, Rzeszów
Galderma Investigational Site, Szczecin
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Wroclaw
Galderma Investigational Site, Wroclaw
Galderma Investigational Site, Seoul
Galderma Investigational Site, Seoul
Galderma Investigational Site, Seoul
Galderma Investigational Site, Seoul
Galderma Investigational Site, Barcelona
Lead Sponsor
Galderma R&D
INDUSTRY